Animal health product developer Bactana is advancing Cornell University research into probiotics that could lead to improved vitality for livestock including cattle, swine and poultry.

Bactana, a US-based animal health product developer that has licensed Cornell University research, has closed a $1.3m equity round featuring Cornell and Connecticut Innovations, the venture capital vehicle for the State of Connecticut.
VC fund Sustainable Income Capital Management also took part in the round, as did unnamed additional funds and private investors. The deal includes conversions of existing debt and interest instruments.
Founded in 2016, Bactana has devised a microbiome discovery platform that identifies targets in the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?